Aveshka announces Dr. Til Jolly as Chief Medical Officer

WASHINGTON, Aug. 10, 2020 /PRNewswire/ — Aveshka announced Dr. Til Jolly will join the company’s executive team as the Chief Medical Officer (CMO). 

Dr. Jolly is a board-certified emergency physician with a wide range of experience in the government and private sector. He served as a part-time consultant to Aveshka since 2019 as the Senior Emergency Care Consultant to the Assistant Secretary for Preparedness and Response at the Department of Health and Human Services and will continue to support these areas.

Previously, Dr. Jolly served in myriad capacities to include CMO of SOC Telemed, Deputy CMO and Associate CMO with the Department of Homeland Security (DHS) Office of Health Affairs (OHA), and Senior Science Advisor for the National Exercise Division of the Federal Emergency Management Agency (FEMA). He also worked with the National Football League for 11 Super Bowls, advising on stadium security matters. In these roles, he coordinated across multiple areas of expertise including preparedness, digital health and technology, clinical medicine, public health, and risk communications.

As CMO, Dr. Jolly will directly support clients by providing clinical leadership and direction for all public health and healthcare matters. He will be responsible for all clinical content of Aveshka’s educational programs and contribute to overall product and services priorities, polices, and initiatives that improve preparedness and response within Aveshka’s clients’ environments.

“Dr. Jolly will no doubt be a crucial component of Aveshka’s important work in public health and emergency management,” said Girish Jindia, Aveshka President and CEO. “His vision for Aveshka’s services and ‘all-hazards’ approach is greatly aligned with our goal of continuous improvement and expansion of our capabilities for both current and future customers, while rendering Aveshka as a go-to thought leader in these realms.”

“I look forward to working with Aveshka’s team and helping its growing customer base accomplish their critical missions,” said Dr. Jolly. “The intersection of health with all threats across critical infrastructure has always been apparent, but in today’s environment is at the top of every leader’s priority list. Digital health and other innovations provide opportunities to approach health threats in new and exciting ways.”

ABOUT AVESHKA, INC.
Aveshka is a thought leader that integrates strategy, technology and innovation to deliver cutting edge, breakthrough solutions that strengthen the nation against security threats. Aveshka accelerates the advantage for its customers’ missions, rendering them protected today and prepared for a safer and smarter tomorrow. Visit www.aveshka.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/aveshka-announces-dr-til-jolly-as-chief-medical-officer-301109093.html

SOURCE Aveshka, Inc.

Staff

Recent Posts

Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship

The New Year Introduces Continuum's Entry-Level Tier, Starting at $25,000 Per YearNEW YORK, Dec. 22,…

2 hours ago

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with…

2 hours ago

KLAS Report Shows Strong Early Results for TrustCommerce Cloud Payments

CHICAGO, Dec. 22, 2025 /PRNewswire/ -- TrustCommerce®, a Sphere company and leading provider of end-to-end…

2 hours ago

BioFlorida Announces Appointment of Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of the Southeast Chapter

MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is…

2 hours ago

Truemed Closes $34 Million Series A To Unlock HSA/FSA Funds For Lifestyle Interventions

Andreessen Horowitz leads the funding round which will accelerate the company's leadingtelehealth marketplaceAUSTIN, Texas, Dec.…

2 hours ago

Trump’s Marijuana Schedule III Order Launches a Federally Regulated Healthcare Sector

MMJ's position is further fortified by its FDA Orphan Drug Designations for the treatment of…

2 hours ago